Recruiting Pulmonary Hypertension Studies in Stanford
About Pulmonary Hypertension Clinical Trials in Stanford
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 25 pulmonary hypertension clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 20,443 participants. Research is being sponsored by Stanford University, Pulmonary Hypertension Association, Inc., Bristol-Myers Squibb and 19 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Stanford — FAQ
Are there pulmonary hypertension clinical trials in Stanford?
Yes, there are 25 pulmonary hypertension clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 25 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 20, 2026 from ClinicalTrials.gov